Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 1,340.50 +9.50 (0.71%)
price chart
How Safe Are These 5%-plus Yields? GlaxoSmithKline plc, HSBC Holdings plc ...
GlaxoSmithKline (LSE: GSK) currently yields 6.08%, an incredible return from one of the most solid UK dividend payers.
Why Growth Is Expected To Take Off At GlaxoSmithKline plc, Barclays PLC ...
Thanks to the effect of enduring patent losses across key labels, GlaxoSmithKline (LSE: GSK) is not expected to see the bottom line light up any time soon.
Head To Head: Barclays plc vs GlaxoSmithKline plc
But if chosen well, your portfolio of shares could appreciate strongly once confidence returns to shares. The question is, what should you buy?
Should You Protect Your Portfolio With Defensive Stocks National Grid plc ...
With stock markets extending last week's losses, investors could reduce their risks by shifting into defensive shares. Having a mix of defensive and cyclical shares in your investment portfolio could help to reduce the volatility of your investment ...
Could Neil Woodford Be Wrong About GlaxoSmithKline plc And AstraZeneca plc?
Neil Woodford is one of AstraZeneca (LSE: AZN) GlaxoSmithKline's (LSE: GSK) most vocal supporters. The star fund manager has sung the praises of Astra and Glaxo's management many times over, and he commended Astra's decision to turn down US ...
GlaxoSmithKline PLC (NYSE:GSK) Price Target Update
GlaxoSmithKline PLC (NYSE:GSK): 2 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $48.5 in GlaxoSmithKline PLC (NYSE:GSK). However, the stock price could fluctuate by $ 4.95 from the estimate as it is ...
Large Outflow of Money Witnessed in GlaxoSmithKline PLC  Money Flow Index
GlaxoSmithKline PLC (NYSE:GSK) Given PT Range of $45-$52  Markets Daily
Societe Generale Reiterates "Sell" Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “sell” rating reissued by stock analysts at Societe Generale in a note issued to investors on Friday, Marketbeat.
GlaxoSmithKline plc Rating Reiterated by JPMorgan Chase & Co. (GSK)  The Legacy
GlaxoSmithKline plc Given Sell Rating at Societe Generale (GSK)  WKRB News
Is Pfizer Inc. Considering A �19-Per-Share Offer For GlaxoSmithKline plc?
GlaxoSmithKline's (LSE: GSK) shares have been on fire this week, outpacing the wider FTSE 100 by more than 3% over the past five days.
3 Reasons To Buy GlaxoSmithKline plc And Sell Quindell PLC Today
GlaxoSmithKline (LSE: GSK) and Quindell (LSE: QPP) are both heavily traded by private investors. But that's where the similarity ends.
Is GlaxoSmithKline plc A Better Buy Than Smith & Nephew plc And Hikma ...
For investors in Smith & Nephew (LSE: SN) and Hikma (LSE: HIK), the last five years have been superb. That's because the two health care companies have posted share price gains of 107% and 224% respectively, which is well ahead of the FTSE 100's rise ...